Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Dexmedetomidine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1/2 (1)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07751835Phase 1/2Not Yet RecruitingPrimary

Effect of Height Based vs Conventional Dose of Spinal Anesthesia in Lower Limb Surgeries

NCT05041270Not ApplicableCompletedPrimary

Epidural Nalbuphine Versus Dexmedetomidine as Adjuvants to Bupivacaine in Lower Limb Surgeries

Showing all 2 trials

Research Network

Common Treatments

  • Dexmedetomidine1
  • Height Based Dose Of Hyperbaric Bupivacaine 051
  • Normal Saline1
  • Nalbuphine1

Active Sponsors

  • Zagazig University1
  • Liaquat National Hospital & Medical College1

Top Investigators

Activity Timeline